Management of atrial fibrillation in patients taking targeted cancer therapies

Atrial fibrillation (AF) is frequently observed in patients being treated for cancer and can lead to increased morbidity and mortality in this population. With the use of newer, targeted cancer therapies, several drug-drug interactions have emerged that complicate the use of antiarrhythmic drugs (AA...

Descripción completa

Detalles Bibliográficos
Autores principales: Asnani, Aarti, Manning, Anastasia, Mansour, Moussa, Ruskin, Jeremy, Hochberg, Ephraim P., Ptaszek, Leon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048041/
https://www.ncbi.nlm.nih.gov/pubmed/32153998
http://dx.doi.org/10.1186/s40959-017-0021-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048041/
https://www.ncbi.nlm.nih.gov/pubmed/32153998
http://dx.doi.org/10.1186/s40959-017-0021-y

Ejemplares similares